Prevalence and Characteristic of Excessive Daytime Sleepiness in Thai Patients with Parkinson’s disease
Article Sidebar
Published:
Feb 7, 2019
Keywords:
Parkinson’s disease excessive daytime sleepiness sleep attacks
Main Article Content
Abstract
:Objective: To determine the prevalence and characteristic of excessive daytime sleepiness (EDS) in Thai patients with Parkinson’s disease (PD) Methods: The study was a cross-sectional study collecting the data from 160 PD patients at the Center of Excellence for Parkinson’s Disease and Related Disorders at King Chulalongkorn Memorial Hospital during January to May 2017. Epworth Sleepiness Scale (ESS) was used for evaluating the presence of EDS. Sudden onset of sleep or sleep attack was assessed using self-administered questionnaire. Results: 51.25 % of PD patients was male with an average age of 64.03±10.97years. Patients were categorized into 4 groups according to their ESS scores and self-reported experience of sleep attacks, including 1) patients with EDS (ESS score >10)(22.50%) 2)patients with EDS and sleep attacks (6.25%) 3) patients with sleep attacks (3.12%) and 4) patients without EDS or sleep attacks (68.13%). The prevalence of EDS and sleep attacks were 28.75 % and 9.38%, respectively. Those with EDS were more likely to have sleep disturbance during the night that might lead to EDS. Conclusion: EDS and sleep attacks were commonly found in PD patients. Therefore, they should be assessed for EDS and sleep attacks.
Article Details
Section
Research Articles
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-35.
2. Bhidayasiri R, Wannachai N, Limpabandhu S, Choey- tim S, Suchonwanich Y, Tananyakul S, et al. A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease. Neuroepidemiology 2011;37:222-30.
3. Sukying C, Bhokakul V, Udomsubpayakul U. An epide- miological study on insomnia in an elderly Thai population. J Med Assoc Thai. 2003;86:316-24.
4. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease. Mov Disord. 2002;17:775-81.
5. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord. 1998;13:895-9.
6. Lolekha P, Kulkantrakorn K. Quality of life and sleep-related problems in patients with Parkinson’s disease at Thammasat University Hospital. Thammasat Medical Journal. 2010;10:165-74.
7. Van Laar AD, Jain S. non-motor symptoms of Parkinson disease: update on the diagnosis and treatment. Neurologist. 2004;10:185.
8. Avidan A, Hays RD, Diaz N, Bordelon Y, Thompson AW, Vassar SD, et al. Associations of sleep disturbance symptoms with health-related quality of life in Parkinson’s disease. J Neuropsychiatry Clin Neurosc 2013;25:319-26.
9. Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, et al. Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov disord 2014;29:195-202.
10. Joo S, Baik I, Yi H, Jung K, Kim J, Shin C. Prevalence of excessive daytime sleepiness and associated factors in the adult population of Korea. Sleep Med. 2009;10:182-8.
11. Pagel J. Excessive daytime sleepiness. Am Fam Physician. 2009;79:391-6.
12. Slater G, Steier J. Excessive daytime sleepiness in sleep disorders. J Thorac Dis. 2012;4:608.
13. Ghorayeb I, Loundou A, Auquier P, Dauvilliers Y, Bioulac B, Tison F. A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord 2007;22:1567-72.
14. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology. 2001; 57 : 1392-6.
15. Poryazova R, Benninger D, Waldvogel D, Bassetti CL. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 2010;63:129-35.
16. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord. 1999; 14:922-7.
17. Zhu K, van Hilten JJ, Marinus J. Course and risk factors for excessive daytime sleepiness in Parkinson 's disease. Parkinsonism Relat Disord. 2016;24:34-40
18. Ferreira J, Desboeuf K, Galitzky M, Thalamas C, Brefel‐Courbon C, Fabre N, et al. Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkin- son's disease: a clinical survey in PD patients and age‐matched healthy volunteers. Eur J Neurol 2006; 13: 209-14.
19. Távora DGF, de Bruin VMS, Gama RL, Lopes EMS, Jorge IF, de Bruin PFC. The nature of excessive sleepiness and sudden sleep onset in Parkinson׳ s disease. Sleep Sci 2014;7:13-8.
20. Gjerstad M, Aarsland D, Larsen J. Development of daytime somnolence over time in Parkinson’s disease Neurology. 2002;58:1544-6.
21. Körner Y, Meindorfner C, Möller JC, Stiasny‐Kolster K, Haja D, Cassel W, et al. Predictors of sudden onset of sleep in Parkinson's disease. Mov disord 2004; 19: 1298-305.
22. Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003; 18: 659-67.
23. Melamed S, Oksenberg A. Excessive daytime sleepi- ness and risk of occupational injuries in non-shift daytime workers. Sleep. 2002;25:315-22.
24. Setthawatcharawanich S, Limapichat K, Sathirapan- ya P, Phabphal K. Excessive daytime sleepiness and nighttime sleep quality in Thai patients with Parkinson 's disease. J Med Assoc Thai 2014;97:1022-7.
25. Cochran WG. Sampling Techniques. 2nd ed. New York: John Wiley and Sons; 1963.
26. Banhiran W, Assanasen P, Nopmaneejumruslers C, Metheetrairut C. Epworth sleepiness scale in obstruct- tive sleep disordered breathing: the reliability and validity of the Thai version. Sleep and Breath 2011; 15:571-7.
27. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wake- fulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000; 9:5-11.
28. Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel‐Döring F, Frauscher B, et al. Parkinson's disease sleep scale—validation of the revised version PDSS‐2. Mov Disord 2011;26:644-52.
29. Suzuki K, Miyamoto T, Miyamoto M, Suzuki S, Numao A, Watanabe Y, et al. Evaluation of cutoff scores for the Parkinson's disease sleep scale-2. Acta Neurol Scand. 2015;131:426-30.
30. Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times. Mov Disord 2010;25:710-6.
31. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
32. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology. 2006;67:853-8.
33. Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442-6.
34. Videnovic A, Golombek D. Circadian and sleep disorders in Parkinson's disease. Exp Neurol. 2013; 243: 45-56.
35. Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Anderson KN. Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease. Mov Disord. 2014;29:259-62.
36. Knie B, Mitra MT, Logishetty K, Chaudhuri KR. Excessive daytime sleepiness in patients with Parkin- son 's disease. CNS Drugs. 2011;25:203-12.
2. Bhidayasiri R, Wannachai N, Limpabandhu S, Choey- tim S, Suchonwanich Y, Tananyakul S, et al. A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease. Neuroepidemiology 2011;37:222-30.
3. Sukying C, Bhokakul V, Udomsubpayakul U. An epide- miological study on insomnia in an elderly Thai population. J Med Assoc Thai. 2003;86:316-24.
4. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease. Mov Disord. 2002;17:775-81.
5. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord. 1998;13:895-9.
6. Lolekha P, Kulkantrakorn K. Quality of life and sleep-related problems in patients with Parkinson’s disease at Thammasat University Hospital. Thammasat Medical Journal. 2010;10:165-74.
7. Van Laar AD, Jain S. non-motor symptoms of Parkinson disease: update on the diagnosis and treatment. Neurologist. 2004;10:185.
8. Avidan A, Hays RD, Diaz N, Bordelon Y, Thompson AW, Vassar SD, et al. Associations of sleep disturbance symptoms with health-related quality of life in Parkinson’s disease. J Neuropsychiatry Clin Neurosc 2013;25:319-26.
9. Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, et al. Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov disord 2014;29:195-202.
10. Joo S, Baik I, Yi H, Jung K, Kim J, Shin C. Prevalence of excessive daytime sleepiness and associated factors in the adult population of Korea. Sleep Med. 2009;10:182-8.
11. Pagel J. Excessive daytime sleepiness. Am Fam Physician. 2009;79:391-6.
12. Slater G, Steier J. Excessive daytime sleepiness in sleep disorders. J Thorac Dis. 2012;4:608.
13. Ghorayeb I, Loundou A, Auquier P, Dauvilliers Y, Bioulac B, Tison F. A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord 2007;22:1567-72.
14. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology. 2001; 57 : 1392-6.
15. Poryazova R, Benninger D, Waldvogel D, Bassetti CL. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 2010;63:129-35.
16. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord. 1999; 14:922-7.
17. Zhu K, van Hilten JJ, Marinus J. Course and risk factors for excessive daytime sleepiness in Parkinson 's disease. Parkinsonism Relat Disord. 2016;24:34-40
18. Ferreira J, Desboeuf K, Galitzky M, Thalamas C, Brefel‐Courbon C, Fabre N, et al. Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkin- son's disease: a clinical survey in PD patients and age‐matched healthy volunteers. Eur J Neurol 2006; 13: 209-14.
19. Távora DGF, de Bruin VMS, Gama RL, Lopes EMS, Jorge IF, de Bruin PFC. The nature of excessive sleepiness and sudden sleep onset in Parkinson׳ s disease. Sleep Sci 2014;7:13-8.
20. Gjerstad M, Aarsland D, Larsen J. Development of daytime somnolence over time in Parkinson’s disease Neurology. 2002;58:1544-6.
21. Körner Y, Meindorfner C, Möller JC, Stiasny‐Kolster K, Haja D, Cassel W, et al. Predictors of sudden onset of sleep in Parkinson's disease. Mov disord 2004; 19: 1298-305.
22. Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003; 18: 659-67.
23. Melamed S, Oksenberg A. Excessive daytime sleepi- ness and risk of occupational injuries in non-shift daytime workers. Sleep. 2002;25:315-22.
24. Setthawatcharawanich S, Limapichat K, Sathirapan- ya P, Phabphal K. Excessive daytime sleepiness and nighttime sleep quality in Thai patients with Parkinson 's disease. J Med Assoc Thai 2014;97:1022-7.
25. Cochran WG. Sampling Techniques. 2nd ed. New York: John Wiley and Sons; 1963.
26. Banhiran W, Assanasen P, Nopmaneejumruslers C, Metheetrairut C. Epworth sleepiness scale in obstruct- tive sleep disordered breathing: the reliability and validity of the Thai version. Sleep and Breath 2011; 15:571-7.
27. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wake- fulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000; 9:5-11.
28. Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel‐Döring F, Frauscher B, et al. Parkinson's disease sleep scale—validation of the revised version PDSS‐2. Mov Disord 2011;26:644-52.
29. Suzuki K, Miyamoto T, Miyamoto M, Suzuki S, Numao A, Watanabe Y, et al. Evaluation of cutoff scores for the Parkinson's disease sleep scale-2. Acta Neurol Scand. 2015;131:426-30.
30. Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times. Mov Disord 2010;25:710-6.
31. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
32. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology. 2006;67:853-8.
33. Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442-6.
34. Videnovic A, Golombek D. Circadian and sleep disorders in Parkinson's disease. Exp Neurol. 2013; 243: 45-56.
35. Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Anderson KN. Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease. Mov Disord. 2014;29:259-62.
36. Knie B, Mitra MT, Logishetty K, Chaudhuri KR. Excessive daytime sleepiness in patients with Parkin- son 's disease. CNS Drugs. 2011;25:203-12.
